Mangrove Partners’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-390,667
Closed -$5.91M – 218
2023
Q1
$5.91M Hold
390,667
– – 0.39% 71
2022
Q4
$5.42M Hold
390,667
– – 0.31% 83
2022
Q3
$5.32M Hold
390,667
– – 0.31% 87
2022
Q2
$5.72M Buy
+390,667
New +$6.03M 0.28% 89

Other funds holding BCAT

Mangrove Partners's BCAT Position: Q2 2023 in Review

Mangrove Partners sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q2 2023, closing a stake of 390,667 shares — an estimated $5.91M sold.

Mangrove Partners first reported a position in BCAT in Q2 2022 and held it in 4 quarters. The position peaked at $5.91M in Q1 2023. 72 funds tracked by Wall St. Rank hold BCAT as of Q2 2023.

  • Mangrove Partners reported no remaining BlackRock Capital Allocation Term Trust position as of Q2 2023 after selling out during the quarter.
  • Mangrove Partners sold 390,667 BlackRock Capital Allocation Term Trust shares in Q2 2023, an estimated $5.91M.
  • Mangrove Partners first reported a position in BlackRock Capital Allocation Term Trust in Q2 2022 and held it in 4 quarters.
  • Mangrove Partners's BlackRock Capital Allocation Term Trust position peaked at $5.91M in Q1 2023.
  • 72 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2023.

Based on Mangrove Partners's 13F filing for Q2 2023, filed 14 Aug 2023.